TL;DR
- Idea: Derive is a decentralized protocol offering programmable on-chain options, perpetuals, and structured products via its custom Ethereum OP Stack rollup (Derive Chain), delivering institutional-grade performance with self-custody.
- Catalyst: Coinbase listing live on May 27, 2026 and recent governance update increasing fee buybacks and cutting emissions drive token demand.
- Risks: Risks include potential sequencer downtime, regulatory scrutiny of derivatives platforms, reliance on continued protocol adoption, and execution risks in delivering planned features.
- Score: 7.00/ 10
Coin
- Name/ Ticker: Derive (DRV)
- Segment: L2/Derivatives
- Status: listed
- Price: $0.105200
Key Metrics
- Market Cap: $77 625 159
- FDV: $157 870 000
- Circulating Supply: 737 529 683
- Total Supply: 1 500 000 000
- Inflation: 0.35%
Sources
Technology
- USP: Institutional-grade derivatives onchain via a bespoke OP Stack rollup, combining AMM liquidity and off-chain order matching for high throughput and low latency.
- Core Technology: Derive Chain (optimistic Ethereum rollup), Derive Protocol (on-chain settlement, collateral, risk engine), off-chain matcher, Rust-powered orderbook, and AI-powered trading interface.
Roadmap
- 2021-07-01: Seed Round
- 2022-11-01: Strategic Round
- 2024-12-01: Public Sale
- 2024-01-15: Mainnet Launch (Derive L2)
- 2026-04-23: Buyback & Staking Update
- 2026-05-27: Coinbase Listing
Team & Investors
Team
- Co-Founder & CEO โ Nick Forster: Former Susquehanna options trader with Meta product design background
- Co-Founder & Head of Product โ Jake Fitzgerald: Built DeFi products and led UX at top crypto protocols
- CTO & Founder โ Dom Rom: Veteran software architect and scalable systems engineer
- Head of Research โ Sean Dawson: Ex-trader and onchain analytics expert
- Head of Growth โ Dillon Lin: Growth strategist at leading crypto startups
Investors
- Seed Investors โ Seed โข 2021-07-01 โข $3.30M
- Strategic Partners โ Strategic โข 2022-11-01 โข $3.00M
- Angel Investors โ Angel โข 2024-09-01 โข $0.00M
- Public Investors โ Public Sale โข 2024-12-01 โข $0.50M
- Variant Fund โ Undisclosed โข 2026-02-03 โข $0.00M
Total funding: $6.80M
Tokenomics
- Utility: Trading fee payments, protocol governance, staking for insurance fund and incentives, collateral management.
- Vesting: Core contributor allocation of 230M tokens vesting over 4 years starting late 2025.
Pros & Cons
Strengths
- Institutional-grade execution onchain
- Custom OP Stack rollup for scalability
- Comprehensive options and perpetual products
- Strong tokenomics with fee buybacks
- Deep liquidity and portfolio margin
- Off-exchange custody integration
- AI-powered trading interface
- Cross-asset collateral support
- Governance via Derive DAO
- Upcoming Coinbase listing
Weaknesses
- Sequencer downtime risk
- Regulatory uncertainty for derivatives
- Dependence on Ethereum ecosystem
- Relatively low TVL vs major DeFi
- Execution complexity for features
- Emission schedule changes may confuse holders
- Centralization in off-chain matching
- Competition from CEX derivatives
- Liquidity fragmentation risk
- Limited retail awareness
Market Signals (7d)
- TVL trend: stable
- CEX volume trend: increasing
- Active addresses trend: increasing
Price Scenarios (target: 2026-11-27)
- Bear: $0.080000 โ Assumes listing momentum fades and price reverts to pre-listing mean of $0.08.
- Base: $0.120000 โ Assumes moderate adoption and sustained fee buybacks driving a 15% price increase.
- Bull: $0.200000 โ Assumes strong institutional integration and network effects doubling the current price.
How to Buy & Store
CEX
- Coinbase
- Binance
- Kraken
- OKX
- Bitget
DEX
- Uniswap V3
- SushiSwap
- 1inch
- Balancer
- Gate.io
Storage
- MetaMask
- Ledger
- Trezor
- Trust Wallet
- Safe
Verdict
Derive combines a unique L2 rollup architecture, institutional-grade product suite, and strong tokenomics, amplified by the Coinbase listing catalyst. Execution and regulatory risks remain, but the protocol is well-positioned for growth.
Official Links
Source: Coin Research (internal)
Comments (0)